Canaccord upgraded Intuitive Surgical Inc. to “buy.” The firm’s analysts said the stock’s recent decline was not surprising, given negative studies and criticisms of robotic surgery. Such surgery (directed by a doctor at a control panel) for hysterectomies does not improve outcomes and should not be most patients’ first choice, the American Congress of Obstetricians and Gynecologists has said; new technology may have higher rates of complications. Intuitive designs and makes da Vinci Surgical Systems. Still, Canacord said that upside potential outweighs downside risk for the stock.
Surgical robot maker gets an upgrade
You have reached the limit of 10 free articles a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than $1 a week